Introduction
NCI Special Notes
Funded K05 Grants
Submitting an Application
Peer Review Process
Frequently Asked Questions
NCI Staff Contacts
Introduction
The purpose of the NCI Established Investigator Award in Cancer Prevention, Control, Behavioral and Population Sciences Research (K05) is to provide established investigators protected time to devote to research and to act as mentors for young investigators. The target candidates are outstanding, established scientists who have demonstrated a sustained, high level of productivity, research accomplishments, and contributions to cancer prevention, control and population sciences research, and who can demonstrate the need to sustain an intensive research focus that will enhance the progress of their own research and provide them greater opportunity to serve as mentors to new scientists. The award provides salary support and other costs for up to five years and can be renewed for an additional 5-year period.
Candidates must be established cancer scientists with a strong track record of publications and successful competition for cancer research support. They must have peer-reviewed, independent research support at the time of and during the entire duration of the award, must have a record of supervising junior researchers, and must commit up to 50 percent (minimum of 25 percent) to research specifically relevant to this award.
At the time of the award, candidates must be citizens or noncitizen nationals of the United States, or must have been lawfully admitted to the United States for permanent residence (i.e., in possession of a currently valid Alien Registration Receipt Card (1-151 or 1-551), or other legal verification of such status. Individuals on temporary or student visas are not eligible for this award.
The K05 award supports salary (up to the current Federal salary rate limit plus commensurate fringe benefits for up to 50 percent effort), research development support (up to $25,000 per year) for tuition, fees and books, research expenses, statistical services and travel to research meetings, and ancillary personnel costs (mentors, secretaries, and administrative assistants), and facilities and administrative costs (reimbursed at 8 percent).
PAR-05-145 ESTABLISHED INVESTIGATOR AWARD IN CANCER PREVENTION, CONTROL, BEHAVIORAL, AND POPULATION SCIENCES (K05)
Back to Top
NCI Special Notes
This is an NCI-specific program announcement. For all of the policies governing this
award mechanism, refer to the Program Announcement:
PAR-05-145 ESTABLISHED INVESTIGATOR AWARD IN CANCER PREVENTION, CONTROL, BEHAVIORAL, AND POPULATION SCIENCES (K05)
Under the
NIH Data Sharing Policy, grantees are expected to engage in a timely release of final data sets that have been generated with NIH support for use by other researchers, provide a Data Sharing Plan that will achieve this objective, OR state why data sharing is not possible or appropriate. Because grantees who hold a K05 grant are independent, established investigators, they are responsible to share the data and provide an acceptable Data Sharing Plan to the NIH as part of their NIH grant support. With regard to the data generated by trainees working in research environments funded by NIH research grants, it is the responsibility of the institutions that are awarded these research grants to share the data and provide acceptable Data Sharing Plans to the NIH as part of the research application.
Back to Top
Funded K05 Grants
| # | Grant Number | Principal Investigator Name | Project Title | Institution |
| 1 | 5K05CA098133-04 | ANDERSEN, BARBARA | Biobehavioral Responses to Cancer | OHIO STATE UNIVERSITY |
| 2 | 5K05CA096558-04 | ANDRYKOWSKI, MICHAEL A. | Psychological and Behavioral Impact of Cancer Screening | UNIVERSITY OF KENTUCKY |
| 3 | 1K05CA115571-01A2 | BIRKMEYER, JOHN D | Understanding Racial Disparities in Cancer Surgery | UNIVERSITY OF MICHIGAN AT ANN ARBOR |
| 4 | 5K05CA111696-03 | DALY, MARY BERYL | Benign Breast Disease: A New Frontier for Prevention | FOX CHASE CANCER CENTER |
| 5 | 5K05CA104699-04 | ELMORE, JOANN G | Improving Accuracy & Outcomes of Breast Cancer Screening | UNIVERSITY OF WASHINGTON |
| 6 | 1K05CA124415-01A1 | EMMONS, KAREN M | Dissemination Research to Reduce Cancer Disparities | DANA-FARBER CANCER INSTITUTE |
| 7 | 5K05CA108575-03 | GIVEN, CHARLES W | Integrating Symptom Trials: Secondary Analyses | MICHIGAN STATE UNIVERSITY |
| 8 | 5K05CA111340-02 | KATZ, STEVEN J. | Quality of Cancer Care Evaluation and Interventions | UNIVERSITY OF MICHIGAN AT ANN ARBOR |
| 9 | 2K05CA096940-06 | MANDELBLATT, JEANNE | Cancer Control at the Intersection of Aging Research | GEORGETOWN UNIVERSITY |
| 10 | 5K05CA109008-04 | MANNE, SHARON L | Improving Marital Support For Couples Coping with Cancer | FOX CHASE CANCER CENTER |
| 11 | 5K05CA100048-05 | MASON, JOEL B | One-carbon nutrients in cancer prevention | TUFTS UNIVERSITY BOSTON |
| 12 | 5K05CA100051-05 | MAYER, JONI A | Community-based Skin Cancer Prevention Research | SAN DIEGO STATE UNIVERSITY |
| 13 | 5K05CA108955-04 | REDD, WILLIAM H | Research and Mentoring in Psychosocial Oncology | MOUNT SINAI SCHOOL OF MEDICINE OF NYU |
| 14 | 5K05CA092395-07 | SILLIMAN, REBECCA A | Cancer Control in Older Adults | BOSTON MEDICAL CENTER |
| 15 | 5K05CA108663-04 | SORENSEN, GLORIAN C | Reducing social disparities in cancer risk | DANA-FARBER CANCER INSTITUTE |
| 16 | 1K05CA124911-01A1 | VAUGHAN, THOMAS L | Established Investigator Award in Cancer Prevention and Control | FRED HUTCHINSON CANCER RESEARCH CENTER |
| 17 | 5K05CA102582-04 | VON GUNTEN, CHARLES F | Academic Palliative Care | SAN DIEGO HOSPICE AND PALLIATIVE CARE |
Back to Top
Submitting an Application
Applications are to be submitted using the
PHS 398 Form (Revised 9/2004), following the instructions in Section
III, "Preparing an Individual CDA Application". It is suggested that you print,
if possible, the pages of
PHS 398 Form (Revised 9/2004) and carefully review all pages,
especially the section titled "NOTABLE CHANGES MADE TO PHS 398. This section
contains information to facilitate the completion of your application.
IMPORTANT NOTE:
Because the instructions in the
PHS 398 Form (Revised 9/2004) are for 'mentored' awards, and do not
entirely apply to the K05 award, please also refer to the APPLICATION
PROCEDURES section of the Program Announcement: PAR-05-145 ESTABLISHED INVESTIGATOR AWARD IN CANCER PREVENTION, CONTROL, BEHAVIORAL, AND POPULATION SCIENCES (K05).
The PHS 398 Form (Revised 9/2004) is also available at most institutional
offices of sponsored research and from the Division of Extramural Outreach and
Information Resources, Office of Extramural Research, NIH, Phone (301)
435-0714, Fax (301) 480-0525, E-mail: GrantsInfo@nih.gov.
| |
Receipt Date: New Application |
Receipt Date: Competing Continuation, Supplement and Amended Application |
Initial Review |
Council Review |
Earliest Possible Start Date * |
| Receipt Cycle 1 |
February 12 |
March 12
|
June/July |
September/October |
December |
| Receipt Cycle 2 |
June 12 |
July 12
|
October/November |
January/February |
April |
| Receipt Cycle 3 |
October 12 |
November 12 |
February/March
|
May/June |
July |
If the application receipt date falls on a weekend, the application must be postmarked by the application receipt date and received at the Center for Scientific Review (CSR) by the following Monday.
If the application receipt date falls on a holiday, (but not on a weekend), the application must be postmarked by the application receipt date and received at CSR by the following day.
* Start dates are determined by the availability of NCI funds and may not occur until well after the earliest possible start date.
Back to Top
Peer Review Process
Upon receipt, applications will be reviewed by the Center for Scientific Review (CSR) and the National Cancer Institute (NCI) for completeness and conformance to all eligibility Upon receipt, competing applications will be reviewed both by the Center for Scientific Review (CSR) and the National Cancer Institute (NCI) for completeness and for conformance to all eligibility requirements and special provisions and requirements. Incomplete applications will be returned to the applicant without further consideration.
Those applications judged to be complete and eligible will be evaluated, according to the review criteria listed in the Program Announcement, by a peer review group convened by the Division of Extramural Activities of the NCI. Applications will receive a second level review by the National Cancer Advisory Board (NCAB) to determine if the application meets the broad program needs and priorities of the NCI and the National Cancer Program.
For review criteria for the K05 grant mechanism, see the
REVIEW CRITERIA section of the Program Announcement:
PAR-05-145 ESTABLISHED INVESTIGATOR AWARD IN CANCER PREVENTION, CONTROL, BEHAVIORAL, AND POPULATION SCIENCES (K05)
Back to Top
Frequently Asked Questions
1. Can a K05 be awarded for less than 5 years?
Yes. The peer review committee determines the length of the award. However, we
recommend that everyone submit an application requesting five years of support.
It would be highly unusual for a review committee to perceive a problem that
would result in a reduction of the grant period to less than five years.
2. I do not have an NIH research grant, but do have independent research support
from other sources. Am I still eligible to apply for a K05?
You are eligible to apply for a K05 award as long as you can document
independent support for your program, regardless of the source. Examples of
appropriate sources of funding could include private foundations and
pharmaceutical companies. Funding may also come from your institution, if you
can document that the use of these funds is completely under your control.
3. I am the Principal Investigator (PI) on a subproject of a cooperative
agreement research grant (U01) awarded to our institution. Is this considered
independent support?
It depends on whether the U01 is comparable to a single project R01 grant or to
a multi-project Program Project Grant (P01). If the U01 resembles an R01 in
size and complexity, a subproject would not be regarded as independent support.
But if you are a leader of a subproject of a grant such as the U01, which is
peer-reviewed as a freestanding project, then this subproject is clearly
equivalent to an R01 and would be considered your independent support. These
kinds of interpretations are difficult to make; if you are unsure of your
independent support, contact the NCI (see
NCI Staff Contacts).
4. I am an established senior investigator who is the PI of a cooperative
agreement grant (U01). The U01 involves the establishment, maintenance and
analysis of a surveillance research database. Since the U01 is not entirely
research-based but does have a research component, am I still eligible to apply
for a K05 award?
If you are the principal investigator, the grant has a research component, and
the research support on the grant provides you with a base of support upon
which to expand and refine your research as well as provide a research
environment in which to mentor new scientists, you are eligible.
5. How strong must the statement of institutional commitment be to the percent
effort required by the K05?
It is important that the institution provide a very specific plan for reducing
your current duties and providing you with the protected time for conducting
your research and mentoring new scientists. Peer reviewers will want to know
how others will accommodate your previous duties. Letters of support for this
plan from key people who must support it in the institution are also important
to include with your application.
6. I have an established record of independently funded research, but do not have
a track record in mentoring. Should I apply for a K05?
Most applicants for the K05 will have extensive mentoring experience. The best
course of action is to develop a mentoring track record and then apply.
7. What happens if I am not able to maintain independent research support during
the tenure of the award?
The K05 requires that you have independent support at the time of the award and
throughout the entire grant period. If you lose your support, you will lose the
K05. Without support you can neither expand, refine your own research program,
nor provide a suitable environment for mentoring new scientists.
8. As part of the mentoring component of the K05, am I allowed to mentor
individuals at another institution?
This could be done, but the arrangements would have to be very carefully
considered to ensure that the trainee(s) can function off-site and benefit from
your funded research environment.
9. If human subjects are to be involved in my K05 program, and I currently have
Institutional Review Board (IRB) approval for my ongoing research, do I still
need IRB approval for this award?
You will be required to obtain IRB approval for any NEW research that is being
proposed involving human subjects. Ongoing research with prior IRB approval
does not need additional action.
If the study is new and deals with human subjects, you must answer all parts of
item 4 on the face page of the
PHS 398 Form (Revised 9/2004) application. NIH requires documentation
of Institutional Review Board (IRB) approval at the time of award. The
application should also address the points concerning Gender and Minority
Inclusion and Inclusion of Children as Participants, OR provide sufficient
information/justification for exemptions. This information can be found in the
Human Subjects Research section of the instructions for preparing a
PHS 398 Form (Revised 9/2004) application.
If the study involves a clinical trial, you will need to include an abbreviated
data and safety-monitoring plan showing that the sponsoring institution does
have an operational mechanism for data and safety monitoring of clinical
trials.
If you are using vertebrate animals, you must answer all parts of item 5 on the
face page of the PHS
398 Form (Revised 9/2004) application and follow the instructions in
the Vertebrate Animals section of the instructions for preparing a
PHS 398 Form (Revised 9/2004) application.
Without the proper information on Gender and Minority Inclusion, Inclusion of
Children and Vertebrate Animals, an award cannot be made. If an application is
fundable, the NCI must be provided with the human subject IRB certification
before an award can be made; and, where appropriate, a detailed data and safety
monitoring plan.
10. Where do I send my application?
All grant applications are sent to one address that is cited in the PHS 398
Form (Revised 9/2004) application kit. The Center for Scientific Review (CSR)
receives all applications and distributes them to the appropriate institutes
and centers. The institutes and centers operate and manage the peer review
groups that review your application for scientific merit.
11. At the time of the application, do I have to provide a list of the
individuals I plan to mentor?
While you are not required to provide specific names of trainees in the
application, providing the names at the time of the application may increase
the enthusiasm of the reviewers for your application. In any case, you should
provide information about the pool of candidates for mentoring, the types of
individuals you would be looking for, and the probable assignments of these
individuals on patient-oriented research projects.
12. I am planning to submit a K05 application but will be moving to another
institution. Should I submit the application now, or should I wait until I make
the move to the new institution?
Please wait until you move to the new institution before submitting the
application. Moving the application from one institution to another would
require a statement from the new institution guaranteeing you protected time.
If reviewers know you are going to move, this would complicate their evaluation
of the application.
13. If I receive additional independent support prior to the review of my K05
application, should I provide the NCI with this information?
Yes. You should contact the Scientific Review Administrator in the NCI, who is
responsible for organizing and managing the review of your application, and
arrange a time and method for providing this information. This kind of
information can only strengthen the peer reviewers' enthusiasm for the
application.
14. If I have a K05 award and would like to ask for post award changes, how do I
go about this?
You must contact the NCI Grants Administration official to determine the
appropriate procedures to use in making a request for post award changes in
your grant. This also applies to any of your needs that require a prior
approval from the NCI. In general, you will have to make a request that is
signed by you and a business official of your institution. After receiving the
request, the Grants Administration official will consult with the NCI
scientific program staff as necessary to determine whether the request can be
approved.
Back to Top
NCI Staff Contacts
For additional information regarding policies and/or guidance in preparing an application for the K05 Award, contact:
Dr. Shannon M. Lemrow
Program Director
Telephone: (301) 496-8580
Fax: (301) 402-4472
E-mail: lemrows@mail.nih.gov
For information regarding fiscal and/or budget issues, contact:
Grants Administration Branch
Phone: (301) 496-3179
Fax: (301) 496-8601
For information regarding review issues, contact:
Referral Officer
Division of Extramural Activities
Phone: (301) 594-1403
Fax: (301) 402-0275
Back to Top
|